Hemodynamic Changes of Hepatic & Renal Vessels in Systemic Bacterial Infection with Fever in HCV Related Cirrhosis

Author:

Helal Eman Mohammed1,Sharaf-Eldin Mohamed1,Abou El Azm Abdel Raouf1,Badr Eldin Nagwa Mansour2,Dawoud Mohammed Mahmoud3,Abd-Elsalam Sherief1,Ziada Dina Hazem1

Affiliation:

1. Department of Tropical Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt

2. Department of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt

3. Department of Radio-diagnosis, Faculty of Medicine, Tanta University, Tanta, Egypt

Abstract

Objective: To study the hemodynamic changes of hepatic & renal vessels in systemic bacterial infection with fever in HCV related cirrhosis with possible complications. Methods: Three groups of patients with systemic bacterial infection with fever were included in the study; group І included 15 patients with decompensated cirrhosis, group ІІ included 15 patients with compensated cirrhosis and group ІІІ included 10 patients without liver affection. Laboratory parameters and Doppler US of hepatic and renal vessels were evaluated during and after subsidence of fever in all patients. Results: Forty patients were enrolled in this prospective study. There were 22 male and 18 female patients. We found that the direction of blood flow in the portal and splenic veins was hepatopetal and the veins were non pulsatile in all cases with no change during and after subsidence of infection. There was no significant difference in portal or splenic vein diameters during and after subsidence of infection in the three studied groups. However, the mean values of portal and splenic veins peak velocities were significantly lower during infection in cirrhotic groups. The mean value of hepatic artery resistive index during fever was significantly higher than after fever in cirrhotic groups. Renal resistive and pulsatility indices were significantly higher during fever in cirrhotic groups. Conclusion: Systemic bacterial infection with fever can affect hepatic haemodynamics leading to aggravation of portal hypertension and increasing the risk of complications as variceal bleeding and hepatic encephalopathy and can also affect renal haemodynamics with increased risk of renal impairment.

Publisher

Bentham Science Publishers Ltd.

Subject

Microbiology (medical),Pharmacology,Molecular Medicine,General Medicine

Reference21 articles.

1. Abd-Elsalam S.; Sharaf-Eldin M.; Soliman S.; Elfert A.; Badawi R.; Ahmad Y.K.; Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice. Arch Virol 2018,163(1),51-56

2. Ahmed O.A.; Kaisar H.H.; Hawash N.; Samir H.; Shabana S.S.T.; Hassan A; Fouad M.; Rizk F.; Abd-Elsalam S.; Abd-Elsalam S.; Effica-cy of sofosbuvir plus ribavirin with or without peginterferon-alfa in treatment of a cohort of Egyptian patients with hepatitis C virus infection. Infect Disord Drug Targets 2017,17(2),95-100

3. Ahmed O.A.; Kaisar H.H.; Badawi R.; Hawash N.; Samir H.; Shabana S.S.; Fouad M.H.A.; Rizk F.H.; Khodeir S.A.; Abd-Elsalam S.; Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection. Infect Drug Resist 2018,11,295-298

4. Ahmed O.A.; Elsebaey M.A.; Fouad M.H.A.; Elashry H.; Elshafie A.I.; Elhadidy A.A.; Esheba N.E.; Elnaggar M.H.; Soliman S.; Abd-Elsalam S.; Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection. Infect Drug Resist 2018,11,441-445

5. Ahmed O.A.; Safwat E.; Khalifa M.O.; Elshafie A.I.; Fouad M.H.A.; Salama M.M.; Naguib G.G.; Eltabbakh M.M.; Sherief A.F.; Abd-Elsalam S.; Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village. Int J Hepatol 2018

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3